Teva CEO: Schizophrenia Drug Market Has $2 Billion in Annual Potential
Teva Pharmaceuticals CEO Richard Francis projects $1.5-2 billion annual sales for its schizophrenia treatments following FDA approval of WELTRUZA.
Sunday, 11 October 2026
Israel's Ministry of Culture announces the return of Israeli Cinema Day on October 14, 2026, offering 10 NIS movie tickets...
Read More →A massive 85-foot Chinese electric bi-articulated bus, nicknamed "train on wheels," has arrived in Israel for a pilot program to...
Read More →Israel's budget deficit is narrowing as Nvidia's booming Israeli operations drive a 10.4% rise in state revenues for 2026.
Read More →Two Israeli activists were detained in Samaria near Yasuf village after a clash with security forces, later released under restrictive...
Read More →Teva Pharmaceuticals CEO Richard Francis projects $1.5-2 billion annual sales for its schizophrenia treatments following FDA approval of WELTRUZA.
Read More →Israel's One Zero digital bank will lay off up to 10% of its workforce, citing AI and automation, as it...
Read More →Air Haifa is now selling tickets for its new Ben-Gurion Airport to Eilat route, with introductory fares as low as...
Read More →IDF female intelligence observers in the Jordan Valley successfully intercepted over 35 weapons and two infiltrators, preventing potential terror plots.
Read More →Shas and United Torah Judaism, led by Aryeh Deri and Yaakov Asher, signed a surplus-vote agreement to boost their Knesset...
Read More →Teva Pharmaceuticals CEO Richard Francis projects $1.5-2 billion annual sales for its schizophrenia treatments following FDA approval of WELTRUZA.